Last update 01 Nov 2024
Valderm ApS
Last update 01 Nov 2024
Overview
Related
A phase IIa, multicenter, randomized, two-arm, observer-blind, vehicle and reference controlled proof of concept trial to investigate intra-individually (left/ right) the antipsoriatic efficacy and safety of once daily topical application of Valrubicin cream 1 % in comparison to vehicle and reference product in adult patients with stable plaque psoriasis
A phase IIa, single-center, randomized, observer-blind, placebo- and reference-controlled proof of concept study with intraindividual comparison of treatments to investigate the safety and antipsoriatic efficacy of topical valrubicin formulations in a psoriasis plaque test - Efficacy and tolerability of varubicin cream in concentrations of 0.5 % and 1 % in a PPT
A 13 day placebo- and reference-controlled, double-blind, monocentric, randomized, intraindividual comparative clinical phase IIa study, investigating the efficacy and tolerability of valrubicin cream 0.01 %, 0.1 % and 1 % in a panel of 24 patients with Psoriasis in a Psoriasis plaque test
100 Clinical Results associated with Valderm ApS
Login to view more data
Login to view more data
100 Deals associated with Valderm ApS
Login to view more data
100 Translational Medicine associated with Valderm ApS
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 23 Nov 2024
No data posted
Login to keep update
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free